Paternal exposure and counselling: Experience of a Teratology Information Service

Reproductive Toxicology

Volumn 26, Issue 1, 2008, Pages 42-46

  De Santis, Marco ^a   Cesari, Elena ^a   Cavaliere, Annafranca ^a   Ligato, Maria Serena ^a   Nobili, Elena ^a   Visconti, Daniela ^a   Caruso, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alcohol; Birth defects; Drugs; Paternal exposure; Radiation; Recreational drugs; Teratological counselling; Teratology Information Service

Indexed keywords

ADEFOVIR; ANTIINFECTIVE AGENT; AZATHIOPRINE; CARBAMAZEPINE; CORTICOSTEROID DERIVATIVE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; ETANERCEPT; ETRETIN; FINASTERIDE; GASTROINTESTINAL AGENT; HYPOCHOLESTEROLEMIC AGENT; IMMUNOSUPPRESSIVE AGENT; INTERFERON; ISOTRETINOIN; LAMIVUDINE; LEFLUNOMIDE; MEFLOQUINE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; MYCOPHENOLIC ACID; PHENOBARBITAL; RECREATIONAL DRUG; RIBAVIRIN; SEROTONIN UPTAKE INHIBITOR; THALIDOMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ARTICLE; BIRTH CONTROL; BIRTH DEFECT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COUNSELING; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; FIRST TRIMESTER PREGNANCY; HUMAN; INFORMATION SERVICE; MAJOR CLINICAL STUDY; MALE; RADIATION EXPOSURE; SPERMATOGENESIS; TERATOGENICITY; TERATOLOGY;

ABNORMALITIES, DRUG-INDUCED; ADULT; DIRECTIVE COUNSELING; DRUG INFORMATION SERVICES; HUMANS; ITALY; MALE; PATERNAL EXPOSURE; PHARMACEUTICAL PREPARATIONS; TERATOGENS; TERATOLOGY;

EID: 48249113932     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.06.003     Document Type: Article

References (72)

1. Friedler G. Paternal exposures: impact on reproductive and developmental outcome. An overview. Pharmacol Biochem Behav 55 4 (1996) 691-700
2. Olshan A.F., and Faustman E.M. Male mediated developmental toxicity. Annu Rev Public Health 14 (1993) 159-181
3. Cordier S. Evidence for a role of paternal exposures in developmental toxicity. Basic Clin Pharmacol Toxicol 102 2 (2008) 176-181
4. De Santis M., Cesari E., Ligato M.S., Nobili E., Straface G., and Cavaliere A. Prenatal drug exposure and teratological risk: one-year experience of an Italian Teratology Information Service. Med Sci Monit 14 2 (2008) PH1-PH18
5. De Santis M., Straface G., Caruso A., Carducci B., Cavaliere A.F., and Merola A.M. Risk of drug-induced congenital defects. Eur J Obstet Gynecol Reprod Biol 10 117(1) (2004) 10-19
6. Anderson D. Overview of male mediated development toxicity. In: Robaire B., and Hales B.F. (Eds). Advances in male mediated developmental toxicology: advances in experimental medicine and biology vol. 518 (2003), Kluwer Academic, New York 11-35
7. Trasler J.M., and Doerksen. Teratogen update: paternal exposures reproductive risks. Teratology 60 (1999) 161-172
8. Ji B.T., Shu X.O., Jin F., Linet M.S., Zheng W., and Wacholder S. Paternal cigarette smoking and the risk of childhood cancer among offspring of non-smoking mothers. J Natl Cancer Inst 89 (1997) 238-244
9. Sallmen M., Lindbohm M.L., Anttila A., Taskinen H., Nykyri E., and HemminKi K. Time to pregnancy among the wives of men of men exposed to organic solvents. Occup Environ Med 55 (1998) 24-30
10. Taskienen H., Anttila A., Lindbohm M.L., Sallmen M., and Hemminki K. Spontaneous abortions and congenital malformations among the wives of men occupationally exposed to organic solvents. Scand J Work Environ Health 15 (1989) 345-352
11. Mc Kinney P.A., Fear N.T., Stockton, and UK Childhood Cancer Study Investigators. Parental occupation at periconception: findings from the United Kingdom Childhood Cancer Study. Occup Environ Med 60 (2003) 901-909
12. Lutwak-Mann C. Observations on progeny of thalidomide treated male rabbits. Br Med J 1 (1964) 1090-1091
13. Hales B.F., Smith S., and Robaire B. Cyclophosphamide in the seminal fluid of treated male: transmission to female by mating and effects on progeny outcome. Toxicol Appl Pharmacol 84 (1986) 423-430
14. Bonde J.P., and Christensen J.M. Chromium in biological samples from low level exposed stainless and mild steel welders. Arch Environ Health 46 (2001) 225-229
15. Xiao G., Pan C., and Fu Z. Effect of benzene, toluene, xylene on the semen quality of exposed workers. Chin Med J 112 (1999) 709-712
16. Xiao G., Pan C., Fu Z., Cai Y., and Lin H. Effect of benzene, toluene, xylene on the semen quality and the function of accessory gonad of exposed workers. Ind Health 39 (2001) 206-210
17. Pichini S., Zuccaro P., and Pacifici R.E. Drugs in semen. Clin Pharmacokinet 26 (1994) 221-226
18. Klemmt L., and Scialli A. The transport of chemicals in semen. Birth Defects Res B 74 (2005) 119-131
19. Minor J.L. Reproductive effects of mefloquine HCl (MFQ) in rats and mice. Pharmacologist 18 (1976) 171
20. Trifunac N.P., and Berstein G.S. Inhibition of the metabolism and motility of human spermatozoa by various alkaloids. Contraception 25 1 (1982) 69-87
21. Hendrick V., Gitlin M., Korenman S., and Altshuler L. Antidepressant medications, mood and male fertility. Psychoneuroendocrinology 25 1 (2000) 37-51
22. Kaplan P.W. Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 63 10 Suppl. 4 (2004) S13-S23
23. Prahalada S., Tarantal A.F., Hendrickx A.G., Harris G.S., Ellsworth K.P., and Clarke A.P. Effects of finasteride, a type 2 5 alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology 55 (1997) 119-131
24. Geiger J.M., and Walker M. Is there a reproductive safety risk in male patients treated with acitretin (neotigason/soriatane)?. Dermatology 205 2 (2002) 105-107
25. Lutwak-Mann C., Schmid K., and Keberle H. Thalidomide in rabbit semen. Nature 214 (1967) 1018-1020
26. Teo S.K., Harden J.L., Burke A.B., Noormohamed F.H., Youle M., and Johnson M.A. Thalidomide is distributed into human semen after oral dosing. Drug Metab Dispos 29 (2001) 1355-1357
27. Teo S.K., Denny K.H., Stirling D.I., Thomas S.D., Morseth S.L., and Hoberman. Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits. Birth Defects Res B: Dev Reprod Toxicol 71 (2004) 1-16
28. Laffitte E. Thalidomide, semen distribution, teratogenicity ... and cost. Br J Dermatol 154 3 (2006) 563
29. Brent R.L. Teratogen update-reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 63 2 (2001) 106-112
30. De Santis M., Straface G., Caruso A., Cavaliere A.F., and Carducci B. Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome. Ann Rheum Dis 64 7 (2005) 1096-1097
31. Brent R.L. Teratogen update-reproductive risks of leflunomide (Arava TM); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplanting fathering a child. Teratology 63 (2001) 106-112
32. Brachen M.B., Eshenazi B., McSharry J.E., Sachse K., Hellenbrand K., and Leo-Summers L. Association of cocaine use with sperm concentration, motility and morphology. Fertil Steril 53 (1990) 315-322
33. George V.K., Li H., and Dhabuwala C.B. Effects of long-term cocaine exposure on spermatogenesis and fertility in peripubertal male rats. J Urol 155 1 (1996) 327-331
34. Bracken M.B., Eskenazi B., and Leo-Summers L. Association of cocaine use with sperm concentration, motility, and morphology. Fertil Steril 53 2 (1990) 315-322
35. Yagizi R.A., Odem R.R., and Polakoski K.L. Demonstration of specific binding of cocaine to human spermatozoa. JAMA 266 (1991) 1956-1959
36. Hembree W.C., Nahas G.G., Zeidenberg P., and Huang H.F. Changes in human spermatozoa associated with high dose marihuana smoking. Adv Biosci 22-23 (1978) 429-439
37. Whan L.B., West M.C., Lewis S.E., and McClure N. Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril 85 3 (2006) 653-660
38. Muthusami K.R., and Chinnaswamy P. Effect of chronic alcoholism on male fertility hormones and semen quality. Fertil Steril 84 (2005) 919-924
39. Anderson R.A. The possible role of paternal alcohol consumption in the etiology of the fetal alcohol syndrome. In: Abel E.L. (Ed). Fetal Alcohol Syndrome vol. III (1982), CRC Press 83-112
40. Warner R.H., and Rosett H.L. The effects of drinking on offspring. J Stud Alcohol 36 (1975) 1395-1420
41. Passar K.T., Little R.E., and Noss J. Effect of paternal alcohol consumption before conception on infant birth weight. Teratology 576 (1998) 294-301
42. Johnson E.M. The effects of ribavirin on development and reproduction: a critical review of published and unpublished studies in experimental animals. J Am Coll Toxicol 9 (1990) 551-561
43. Hagenbarth K., Maurer U., Stauber R.E., Kroisel P.M., Fickert P., and Trauner M. No evidence for mutagenic effects of ribavirin: report of two normal pregnancies. Am J Gastoenterol 96 (2001) 2286-2287
44. Taguchi N., and Ito S. Paternal use of ribavirin-interferon alpha 2B combination therapy before conception. Can Fam Physician 51 (2005) 1623-1625
45. Bianca S., and Ettore G. Male periconceptional ribavirin-interferon alpha-2b exposure with no adverse fetal effects. Birth Defects Res A: Clin Mol Teratol 67 1 (2003) 77-78
46. De Santis M., Carducci B., Caruso A., Cavaliere A.F., De Santis L., and Lucchese G. Paternal exposure to ribavirin: pregnancy and neonatal outcome. Antivir Ther 8 1 (2003) 73-75
47. Mishkin D., and Deschenes M. Conception soon after discontinuing interferon/ribavirin therapy: a successful outcome. Am J Gastoenterol 96 (2001) 2285
48. Lok S., Heathcote E.J., and Hoofnagle J.H. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120 7 (2001) 1828-1853
49. Deeks S.G., Collier A., Kahn J., Lalezari J., Pavia A., and Rodrigue D. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J Infect Dis 176 6 (1997) 1517-1523
50. Trojan J., Kronenberger B., Zeuzem S., and von Wagner M. Lack of birthdefects after paternal exposure to lamivudine. J Hepatol 36 4 (2002) 571
51. Martin R., Rademaker A., and Leonard N. Analysis of chromosomal abnormalities in human sperm after chemotherapy by karyotyping and fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 80 (1995) 29-32
52. Genesca A., Benet J., Germa J.R., Caballin M.R., Mirò R., and Egozcue J. Significance of structural chromosome aberrations in human sperm: analysis of induced aberrations. Hum Genet 85 (1990) 495-499
53. Shelby M.D. Human germ cell mutagens. Environ Mol Mutagen 23 Suppl 24 (1994) 30-34
54. Witt K.L., and Bishop J.B. Mutagenicity of anticancer drugs in mammalian germ cells. Mutat Res 355 1/2 (1996) 209-234
55. Robaire B., and Hales B.F. The male germ cell as a target for drug and toxicant action. In: Gagnon C. (Ed). The male gamete: from basic science to clinical applications (1999), Cache River Press, Boca Raton, FL 469-474
56. Brinkworth M.H. Paternal transmission of genetic damage: findings in animals and humans. Int J Androl 23 3 (2000) 123-135
57. Schull W.J., Otake M., and Neel J.V. Genetic effects of the atomic bombs: a reapprasail. Science 213 (1981) 1220-1227
58. Martin R., Hildebrand K., Arthur K., Yamamoto J., Rademaker A., and Barnes M. An increased frequency of human sperm chromosomal abnormalities after radiotherapy. Mutat Res 174 (1986) 219-225
59. Lopez Andreu J.A., Fernandez P.J., Romeu A., Ferris i Tortajada J., Navarro I., and Rodriguez-Ineba A. Persistant altered spermatogenesis in long-term childhood cancer survivors. Pediatr Hematol Oncol 17 (2000) 21-30
60. Byrne J., Mulvihill J.J., Hassinger D.D., Myers M.H., Connelly R.R., and Naughton M.D. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 317 (1987) 1315-1321
61. Sega G.A. Unscheduled DNA synthesis (DNA repair) in the germ cells of male mice: its role in the study of mammalian mutagenesis. Genetics 92 (1979) s49-s58
62. Sotomayor R.E., and Sega G.A. Unscheduled DNA synthesis assay in mammalian spermatogenesis cell: an update. Environ Mol Mutagen 136 (2000) 255-265
63. Byrne J., Rasmussen S.A., Austin D.F., Steinhorn S.C., Connelly R.R., and Myers M.H. Genetic disease in offspring of long term survivors of childhood and adolescent cancer. Am J Hum Genet 62 (1998) 45-52
64. Byrne J. Long term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring. Teratology 59 (1999) 210-215
65. Green D.M., Whitton J.A., Robison L.L., Stovall M., Mertens A.C., and Donaldson S.S. Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 15 21(4) (2003) 716-721
66. Winther J.F., Boice Jr. J.D., Olsen J.H., Mulvihill J.J., Stovall M., and Frederiksen K. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. Am J Hum Genet 74 6 (2004) 1282-1285
67. Robbins W.A., Meistrich M.L., Moore D., Hagemeister F.B., Weier H.U., and Cassel M.J. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet 16 (1997) 74-78
68. Martin R.H. Human sperm chromosome complements in chemotherapy patients and infertile men. Chromosoma 107 (1998) 523-527
69. Hales B.F., and Robaire B. Paternal exposure to drugs and environmental chemicals: effects on progeny outcome. J Androl 22 6 (2001) 927-936
70. Meistrich Ml. Potential genetic risks of using semen collected during chemotherapy. Hum Reprod 8 (1993) 8-10
71. Arfsten D.P., Still K.R., and Ritchie G.D. A review of the effects of uranium and depleted uranium exposure on reproduction and fetal development. Toxicol Ind Health 17 5-10 (2001) 180-191
72. Arfsten D.P., Schaeffer D.J., Johnson E.W., Robert Cunningham J., Still K.R., and Wilfong E.R. Evaluation of the effects of implanted depleted uranium on male reproductive success, sperm concentration, and sperm velocity. Environ Res 100 2 (2006) 205-215